TABLE 4.
Prediction of PES in the overall cohort
| Univariable model | Multivariable model | |||
|---|---|---|---|---|
| Parameter | OR (95% CI) | p | OR (95% CI) | p |
| Age | 1.02 (1.00–1.04) | 0.004 | 0.41 (0.19–0.88) | 0.022 |
| Child score | 0.87 (0.76–0.96) | 0.009 | 0.89 (0.79–0.99) | 0.048 |
| Cirrhosis | 0.48 (0.27–0.84) | 0.011 | 0.89 (0.79–0.99) | 0.048 |
| Viral suppressiona | 0.87 (0.57–1.83) | 0.504 | — | — |
| Multifocal vs. solitary | 0.88 (0.63–1.21) | 0.492 | — | — |
| Max. diameter (cm) | 1.21 (1.13–1.28) | <0.001 | 1.20 (1.12–1.30) | <0.001 |
| Tumorous PVT | 1.04 (0.65–1.67) | 0.873 | — | — |
| Nontumorous PVT | 0.72 (0.48–1.09) | 0.119 | — | — |
| DEB-TACE | 1.99 (1.53–2.64) | <0.001 | 1.71 (1.24–2.35) | <0.001 |
a
Viral suppression was defined as HBV titer ≤20 IU/mL or nondetectable HCV DNA.
Abbreviation: DEB-TACE, drug-eluting bead transarterial chemoembolization.